Free Trial

iTeos Therapeutics (ITOS) SEC Filings & 10K Form

iTeos Therapeutics logo
$8.32 +0.19 (+2.34%)
(As of 11/22/2024 ET)

Recent iTeos Therapeutics SEC Filings

DateFilerForm TypeView
11/21/2024
7:27 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
iTeos Therapeutics (Subject)
Form SC 13G
11/19/2024
6:59 PM
Gall Matthew (Reporting)
iTeos Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2024
8:57 AM
Boxer Capital Management, LLC (Filed by)
iTeos Therapeutics (Subject)
Form SC 13D/A
11/18/2024
8:57 PM
Boxer Capital Management, LLC (Filed by)
iTeos Therapeutics (Subject)
Form SC 13D/A
11/14/2024
5:04 PM
EcoR1 Capital, LLC (Filed by)
iTeos Therapeutics (Subject)
Form SC 13G/A
11/12/2024
6:08 AM
iTeos Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/04/2024
6:00 AM
iTeos Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/15/2024
8:49 PM
Boxer Capital, LLC (Filed by)
iTeos Therapeutics (Subject)
Form SC 13D/A
10/15/2024
6:20 PM
Boxer Asset Management Inc. (Filed by)
iTeos Therapeutics (Subject)
Form SC 13D/A
09/30/2024
8:00 AM
iTeos Therapeutics (Subject)
TANG CAPITAL MANAGEMENT LLC (Filed by)
Form SC 13G
09/16/2024
6:00 AM
iTeos Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/09/2024
7:00 PM
Detheux Michel (Reporting)
iTeos Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2024
6:08 AM
iTeos Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/05/2024
6:16 AM
Feltquate David (Reporting)
iTeos Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/05/2024
6:19 AM
Feltquate David (Reporting)
iTeos Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
7:00 PM
Iannone Robert (Reporting)
iTeos Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
7:00 PM
iTeos Therapeutics (Issuer)
RHOADS ANN D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
7:00 PM
DeSimone Jill (Reporting)
iTeos Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
7:00 PM
Hallal David (Reporting)
iTeos Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
7:00 PM
Davis Aaron I. (Reporting)
iTeos Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
7:00 PM
iTeos Therapeutics (Issuer)
Lee David K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
7:00 PM
iTeos Therapeutics (Issuer)
Van Hauwermeiren Timothy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
7:00 PM
Ho Tony W (Reporting)
iTeos Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
3:01 PM
iTeos Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2024
7:37 AM
Boxer Capital, LLC (Filed by)
iTeos Therapeutics (Subject)
Form SC 13D/A
05/14/2024
8:32 PM
Boxer Asset Management Inc. (Reporting)
Boxer Capital, LLC (Reporting)
Davis Aaron I. (Reporting)
iTeos Therapeutics (Issuer)
LEWIS JOSEPH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2024
8:06 PM
iTeos Therapeutics (Issuer)
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2024
8:10 PM
iTeos Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Form SC 13D/A
05/13/2024
6:01 AM
iTeos Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/10/2024
3:35 PM
iTeos Therapeutics (Filer)
Form 424B5
05/10/2024
7:31 AM
iTeos Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/25/2024
6:13 AM
iTeos Therapeutics (Filer)
Form ARS
04/25/2024
6:03 AM
iTeos Therapeutics (Filer)
Form DEF 14A
04/25/2024
6:07 AM
iTeos Therapeutics (Filer)
Form DEFA14A
03/08/2024
6:57 PM
Detheux Michel (Reporting)
iTeos Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
6:58 PM
iTeos Therapeutics (Issuer)
McGrath Yvonne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
7:00 PM
Call Matthew (Reporting)
iTeos Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
7:01 PM
Gall Matthew (Reporting)
iTeos Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2024
7:00 PM
DeSimone Jill (Reporting)
iTeos Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/07/2024
7:01 PM
DeSimone Jill (Reporting)
iTeos Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
6:09 AM
iTeos Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
2024 Election Year Stocks: Uncover Hidden Gems! (Ad)

In the lead-up to the pivotal 2024 election year, we're excited to present our comprehensive report, "Election Year Investment Gems: Stock Poised To Takeoff In 2024," brimming with insights and opportunities you won't want to miss.

Secure your copy now by clicking this link.
03/06/2024
6:19 AM
iTeos Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/16/2024
11:54 AM
EcoR1 Capital, LLC (Filed by)
iTeos Therapeutics (Subject)
Form SC 13G
02/14/2024
8:45 AM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
iTeos Therapeutics (Subject)
Form SC 13G/A
01/10/2024
4:00 PM
iTeos Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/09/2024
3:26 PM
iTeos Therapeutics (Subject)
MILLENNIUM MANAGEMENT LLC (Filed by)
Form SC 13G/A
12/07/2023
7:20 PM
Detheux Michel (Reporting)
iTeos Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/07/2023
7:21 PM
Gall Matthew (Reporting)
iTeos Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/07/2023
7:22 PM
Call Matthew (Reporting)
iTeos Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/07/2023
7:22 PM
iTeos Therapeutics (Issuer)
McGrath Yvonne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/07/2023
7:16 PM
iTeos Therapeutics (Issuer)
Lee David K (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/07/2023
7:17 PM
iTeos Therapeutics (Issuer)
Lee David K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:ITOS) was last updated on 11/23/2024 by MarketBeat.com Staff
From Our Partners